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Experimental Section. 
 
For the UV-HPLC analysis of nifedipine sample, the mobile phase consisted of solvent A: 5% methanol 
in water; and solvent B: 95% methanol in water. The LC run started with 55% B continued for 25 min, 
followed by a gradient to 80% B in 10 min, and then back to 55% B with a gradient in 5 min. At the end 
of the run, the column was allowed to equilibrate at 55% B for 5min. Absorbance at 254 nm was 
recorded. 
 
For the UV-HPLC analysis of testosterone sample, the mobile phase consisted of solvent A: 5% ACN in 
water; and solvent B: 95% ACN in water. The LC run started with 5% B, followed by a gradient to 50% 
B in 10 min, then to 90% B in 30 min, and back to 5% B by a gradient in 5 min. Absorbance at 244 nm 
was recorded. 
 
Electrospray ionization mass spectrometry (ESI-MS) was run on a 6460 QQQ mass spectrometer 
operated in positive ion mode under the conditions: gas temperature 350 
0
C, gas flow 5 L/min, nebulizer 
gas pressure 310.275 kPa (45.0 psi), sheath gas temperature 250 
0
C, sheath gas flow 11.0 L/min, 
capillary voltage: 4000 V (for positive mode) / -3500 V (for negative mode), Nozzle voltage: 500 V, 
collision energy 30 V. 
 
  
 
 
Figure S1. Adsorption ratio of a) nifedipine, b) testosterone and c) NADPH by NH2-PMO as a function of time. The experiment 
conditions are the same as the metabolic reactions. 
  
Figure S2. UV-HPLC chromatograms of nifedipine sustained-release tablets oxidation by human liver CYP3A4 microsomes with 
and without the assistance of NH2-PMO nanoreactor monitored at 254 nm at a) 2 min and b) 10 min. The nifedipine was observed 
at tR ≈27 min. The metabolite of nifedipine was observed at tR ≈16 min. 
 
 
 
 
Figure S3. UV-HPLC chromatograms of PMO-assisted drug metabolism at 30 min. The nifedipine substrate was observed at tR ≈
27 min. The metabolite of nifeipine was observed at tR ≈16 min. 
 
 
 
Figure S4. Mass spectra of nifedipine oxidation by human liver CYP3A4 microsomes with and without the assistance of NH2-PMO 
at different time: a) 2 min, b) 10 min, c) 30 min, d) 60 min. The peaks of dehydronifedipine: m/z = 345.1 [M+H]
+
, m/z = 367.1 
[M+Na]
+
 and m/z = 711.3 [2M+Na]
+
; the peaks of nifedipine: m/z = 347.1 [M+H]
+
, m/z = 369.1 [M+Na]
+
 and m/z = 715.4 
[2M+Na]
+
. 
 
 
  
 
Figure S5. Mass spectra of testosterone oxidation by human liver CYP3A4 microsomes with and without the assistance of 
NH2-PMO at different time: a) 2 min, b) 10 min, c) 30 min, d) 120 min. The peaks of OH-T: m/z = 305.1 [M+H]
+
, m/z = 327.1 
[M+Na]
+
 and m/z = 631.4 [2M+Na]
+
; the peaks of testosterone: m/z = 289.1 [M+H]
+
 and m/z = 599.4 [2M+Na]
+
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